Korean Idiopathic Pulmonary Fibrosis Registry
Recruiting
Observational Study
Idiopathic Pulmonary Fibrosis
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 30 – 100
- Sex
- Any
- Study type
- Observational
- Participants needed
- 3,000 (estimated)
- Sponsor
- Seoul National University Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This is a multicenter prospective registry of IPF patients in South Korea. The Seoul National University Bundang Hospital is the coordination center for the Korean IPF Registry built by a collaboration of the Korean Interstitial Lung Diseases (ILD) Study Group.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* IPF patients diagnosed by multidisciplinary discussion
Exclusion Criteria:
* Other interstitial lung diseases except for IPF
* connective tissue disease-related ILD
* exposure-related ILD
Contacts